Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Would you like to receive stakeholder email notices about changes to the preferred drug lists?
On the Washington PDL each program's status is listed separately. Preferred or not covered is noted, if a status is left blank the drug is nonpreferred. As an Endorsing Practitioner, the Washington PDL tells you what drugs can be therapeutically interchanged for a preferred drug.
Quarter one | Quarter two | Quarter three | Quarter four
If you are looking for the preferred status of a drug that is not included in the Washington PDL, please check the specific program website.
Changes to preferred drugs covered under the Washington Preferred Drug List and their effective dates are listed below.
Defining a drug’s “preferred” or “nonpreferred” status on the PDL:
Selection process of preferred drugs on the PDL.
For archived drug class updates
Email: Prescription Drug Program